A public health response to the methamphetamine epidemic: the implementation of contingency management to treat methamphetamine dependence

Department of Psychiatry, University of California, San Francisco, San Francisco, California, United States
BMC Public Health (Impact Factor: 2.26). 02/2006; 6(1):214. DOI: 10.1186/1471-2458-6-214
Source: PubMed


In response to increases in methamphatemine-associated sexually transmitted diseases, the San Francisco Department of Public Health implemented a contingency management (CM) field program called the Positive Reinforcement Opportunity Project (PROP).
Methamphetamine-using men who have sex with men (MSM) in San Francisco qualified for PROP following expressed interest in the program, provision of an observed urine sample that tested positive for methamphetamine metabolites and self-report of recent methamphetamine use. For 12 weeks, PROP participants provided observed urine samples on Mondays, Wednesdays and Fridays and received vouchers of increasing value for each consecutive sample that tested negative to metabolites of methamphetamine. Vouchers were exchanged for goods and services that promoted a healthy lifestyle. No cash was provided. Primary outcomes included acceptability (number of enrollments/time), impact (clinical response to treatment and cost-effectiveness as cost per patient treated).
Enrollment in PROP was brisk indicating its acceptability. During the first 10 months of operation, 143 men sought treatment and of these 77.6% were HIV-infected. Of those screened, 111 began CM treatment and averaged 15 (42%) methamphetamine-free urine samples out of a possible 36 samples during the 12-week treatment period; 60% completed 4 weeks of treatment; 48% 8 weeks and 30% 12 weeks. Across all participants, an average of $159 (SD = $165) in vouchers or 35.1% of the maximum possible ($453) was provided for these participants. The average cost per participant of the 143 treated was $800.
Clinical responses to CM in PROP were similar to CM delivered in drug treatment programs, supporting the adaptability and effectiveness of CM to non-traditional drug treatment settings. Costs were reasonable and less than or comparable to other methamphetamine outpatient treatment programs. Further expansion of programs like PROP could address the increasing need for acceptable, feasible and cost-effective methamphetamine treatment in this group with exceptionally high rates of HIV-infection.

Download full-text


Available from: PubMed Central, Dec 17, 2014 · License: CC BY
  • Source
    • "However, interventions are also needed to target gay and bisexual men before they arrive at these events. Behavioral interventions geared towards gay and bisexual men can be effective at promoting responsible substance-using behaviors (Shoptaw et al., 2006; Wong et al., 2008) as well as reducing higher risk sexual activities (Chiasson, Shaw, Humberstone, Hirshfield, & Hartel, 2009; Dilley et al., 2010; Fisher et al., 2006; Hays, Rebchook, & Kegeles, 2003; Jones et al., 2008; Koblin, Chesney, Coates, & Team, 2004; Williams et al., 2008; Wilton et al., 2009) or both types of behaviors (Shoptaw et al., 2008; Velasquez et al., 2009). Such interventions, however, often involve individual or group counseling sessions efforts are needed to increase the reach of these strategies to otherwise healthy gay and bisexual men who may not attend the community centers or health clinics where these are offered and/or may not relate to the language and prevention messages that are delivered (Morales, 2009). "
    [Show abstract] [Hide abstract]
    ABSTRACT: PartyIntents examines whether portal survey methods could be used to anonymously survey gay and bisexual men about HIV-risk behaviors before and after a weekend party-oriented vacation. The study recruited 97% of eligible men and of these 489 participants 47% completed the follow-up assessment. Approximately one half of the men intended to use illegal drugs over the weekend, and almost 20% thought that they might have anal intercourse and not use a condom. The methodology can be applied and provides useful information about HIV risk at these events, though refinements may be needed to increase the follow-up rates.
    Full-text · Article · Sep 2011 · Evaluation Review
  • Source
    • "In recent years there has been increasing concern about the risks of amphetamine use, particularly methamphetamine use (Hirshfield, Remien, Humberstone, Walavalkar, & Chiasson, 2004; Schwartz, Andsager, & LaVail, 2007). Amphetamine use is associated with, for example, increases in cases of HIV and other sexually transmitted diseases (Fisher, Reynolds, Ware, & Napper, 2009; Hirshfield, Remien, Walavalkar, & Chaisson, 2004; Menza, Hughes, Celum, & Golden, 2009; Shoptaw et al., 2006). Attempts to track the use of amphetamines often rely exclusively on self-reports, including efforts to assess the effectiveness of interventions, describe trends in drug use, develop prevention and treatment programs and advocate for financial support for treatment services and law enforcement. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Relatively few studies have addressed the psychometric properties of self-report measures of amphetamine use. This study examines the reliability and validity of the Risk Behavior Assessment's (RBA) lifetime and recent amphetamine-use questions. To evaluate validity, 4027 out-of-treatment primarily cocaine and heroin users provided urine samples that were compared to self-report data; to evaluate reliability, 218 completed the RBA at two time points, 48h apart. In the overall sample, self-reports demonstrated moderately high validity, with a 95% accuracy rate (kappa=.54). When analysis was restricted to recent amphetamine users validity was slightly lower (71.5% accuracy; kappa=.41). Test-retest data indicated good reliability for self-reports of ever having used amphetamine (kappa=.79), and amphetamine use in the past 30 days (.75<r<.91). Out-of-treatment drug users provided accurate self-reports of amphetamine use. Reliable and valid measures are essential for describing and predicting trends in amphetamine use, evaluating the effectiveness of interventions, and developing policies and programs.
    Full-text · Article · Apr 2010 · Addictive behaviors
  • Source
    • "appears to have stabilized, or decreased slightly, abuse in certain populations is increasing (Halkitis et al. 2005; Shoptaw et al. 2006). Abuse potential of drugs, as well as treatments for drug abuse, are often tested in animal behavioral pharmacology models. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Pigeons are used frequently as subjects in behavioral pharmacology research. An advantage of the pigeon is an exceedingly vascular breast muscle, which is easily accessible for injections. The purpose of these studies was to provide a profile of the pharmacokinetics of (+)-methamphetamine (METH) and (+)-amphetamine (AMP), a pharmacologically active metabolite, in pigeons (n=6) after intramuscular (i.m.) and intravenous (i.v.) dosing (0.8 mg/kg). LC-MS/MS analysis was used to determine serum concentrations of METH and AMP. A modified crossover design was used to determine the bioavailability, time to maximum concentration, total clearance, the volume of distribution, the maximal concentration, the area under the concentration-time curve (AUC), and terminal elimination half-life for METH. The route of administration did not significantly affect these pharmacokinetic parameters. The time to maximum concentration for METH and AMP following i.m. administration was 0.3 h. Maximum AMP serum concentrations were achieved in 2 h, irrespective of the route of administration, and these concentrations remained essentially constant for an additional 6 h. The metabolism of METH to AMP was not affected by the route of administration, and the molar ratio AMP to METH AUC values were the same (i.v.=0.57; i.m.=0.41). These results show that METH pharmacokinetics after i.m. administration in the pigeon are similar to i.v. administration. Thus i.m. is a reasonable route of administration for METH behavioral assays in the pigeon if sufficient time for absorption is given following the dose, and the behavioral endpoint is not dependent on the rapid input of METH following an i.v. dose.
    Full-text · Article · Oct 2008 · Pharmacology Biochemistry and Behavior
Show more